This page shows the latest ADA news and features for those working in and with pharma, biotech and healthcare.
Around 8.4 million of the 37 million people in the US with diabetes use insulin, according to the American Diabetes Association (ADA). ... The American Diabetes Association (ADA) issued a statement in response to Novo Nordisk’s cuts, with chief
Another highlight of the event was the joint talk by Ada Palmadottir, vice president of business development at Controlant and Tomas Fant, Temperature Control Logistics Global Projects Lead at Pfizer, joining
Eli Lilly has showcased new positive data for its investigational type 2 diabetes drug tirzepatide at Annual Scientific Sessions of the American Diabetes Association (ADA).
The results, presented at the Annual Scientific Sessions of the American Diabetes Association (ADA), showed that the trial met its primary endpoint – patients with an elevated mean baseline HbA1c of ... Also at ADA, Lilly revealed that all doses of
The study also found no treatment benefit on exploratory efficacy endpoints, including the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog 13), the Alzheimer Disease Cooperative Study Activity of Daily
Patients from a small phase 2a study saw their ADAS-Cog11 scores improve by 4.4 points. ... Specifically, patients in the ANVS401-treated group saw their ADAS-Cog11 scores improve by 4.4 points from baseline until 25 days – an improvement of 30%.
More from news
Approximately 19 fully matching, plus 52 partially matching documents found.
Despite their limitations, available outcome scales, such as the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), are sufficiently sensitive to capture clinically meaningful changes.
GlaxoSmithKline (GSK) launched its gene therapy STRIMVELIS, a one dose treatment for severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), in Europe in 2016 with an outcomes-based annuity
The movement is also distancing itself from some of the big type 1 diabetes advocacy organisations, such as the American Diabetes Association (ADA) and the Juvenile Diabetes Foundation (JDF), which it
Ada is an artificial intelligence (AI) app that helps patients navigate quickly and accurately to the right health service and, ultimately, the right diagnosis. ... So far, Ada has performed eight million assessments around the globe, and every three
GSK’s Strimvelis for ADA-SCID (Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency) followed in 2016, and was a similar commercial failure.
More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.
There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory
The clinical data we’ve seen to date with Orchard’s therapy for ADA-SCID is exceptional, and the company has assembled and impressive R&D pipeline to apply the approach
He previously served as managing director at Medicom International, an international healthcare publishing firm as well as ADA holdings and ICI Pharmaceuticals.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
If not diagnosed and treated promptly, adenosine deaminase severe combined immunodeficiency (usually known as ADA-SCID) often proves fatal within the child’s first years of life. ... 1. The ground-breaking treatment uses a virus to insert functional
In the example of Adenosine deaminase (ADA) deficiency, with an epidemiology of only 1 patient in 230, 000 births for the UK market, many of the leading paediatric consultants may potentially
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
No results were found
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys...